RIGEL PHARMACEUTICALS, INC. Other Current Assets
RIGEL PHARMACEUTICALS, INC. (RIGL) had Other Current Assets of $5.03 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-04
- 2026-06-30: Other Assets, Current $5.03M.
- 2026-03-31: Other Assets, Current $7.13M.
- 2025-12-31: Other Assets, Current $5.21M.
- 2025-09-30: Other Assets, Current $5.86M.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $5.03M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $7.13M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $5.21M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $5.86M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $5.44M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $6.38M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $4.52M 10-K · filed 2026-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |